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Abstract
Background: Coagulase-negative staphylococci are major causes of bloodstream infections in very low birth weight 
babies cared for in Neonatal Intensive Care Units. The virulence of these bacteria is mainly due to their ability to form 
biofilms on indwelling medical devices. Biofilm-related infections often fail to respond to antibiotic chemotherapy 
guided by conventional antibiotic susceptibility tests.
Methods: Coagulase-negative staphylococcal blood culture isolates were grown in different phases relevant to biofilm 
formation: planktonic cells at mid-log phase, planktonic cells at stationary phase, adherent monolayers and mature 
biofilms and their susceptibilities to conventional antibiotics were assessed. The effects of oxacillin, gentamicin, and 
vancomycin on preformed biofilms, at the highest achievable serum concentrations were examined. Epifluorescence 
microscopy and confocal laser scanning microscopy in combination with bacterial viability staining and 
polysaccharide staining were used to confirm the stimulatory effects of antibiotics on biofilms.
Results: Most coagulase-negative staphylococcal clinical isolates were resistant to penicillin G (100%), gentamicin 
(83.3%) and oxacillin (91.7%) and susceptible to vancomycin (100%), ciprofloxacin (100%), and rifampicin (79.2%). 
Bacteria grown as adherent monolayers showed similar susceptibilities to their planktonic counterparts at mid-log 
phase. Isolates in a biofilm growth mode were more resistant to antibiotics than both planktonic cultures at mid-log 
phase and adherent monolayers; however they were equally resistant or less resistant than planktonic cells at 
stationary phase. Moreover, for some cell-wall active antibiotics, concentrations higher than conventional MICs were 
required to prevent the establishment of planktonic cultures from biofilms. Finally, the biofilm-growth of two S. capitis 
isolates could be enhanced by oxacillin at the highest achievable serum concentration.
Conclusion: We conclude that the resistance of coagulase-negative staphylococci to multiple antibiotics initially 
remain similar when the bacteria shift from a planktonic growth mode into an early attached mode, then increase 
significantly as the adherent mode further develops. Furthermore, preformed biofilms of some CoNS are enhanced by 
oxacillin in a dose-dependent manner.
Background
Coagulase-negative staphylococci (CoNS), predomi-
nantly Staphylococcus epidermidis, are the most common
causative agents of neonatal sepsis [1-3], a condition
which has been related to significant morbidity and mor-
tality in neonatal intensive care units (NICUs) [2]. The
presence of a central venous catheter in very low birth
weight (VLBW) babies (< 1500 g) is a significant risk fac-
tor for CoNS-associated neonatal sepsis [3-5].
The pathogenesis of CoNS infections depends on their
ability to form biofilms on polymer surfaces [6-8]. After
initial contact and attachment to a surface, the bacterial
cells become embedded in an extracellular polymer sub-
stance, which is composed of water, exopolysaccharide,
extracellular DNA, proteins, and lipids [9,10]. Once
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grown as a biofilm, the embedded bacteria are protected
from various physical, chemical and biological stresses
[11,12]. Specifically, biofilms formed by CoNS clinical
isolates possess an extremely high level of tolerance to
multiple antibiotics [13,14]. Antibiotic resistance of
CoNS biofilms is likely to have multiple causes including
failure of antibiotics to reach the extracellular polymer
substance embedded biofilm cells, a micro-environment
unfavourable to antimicrobial activity, slow bacterial
growth, activation of stress responses within biofilms,
phenotypically resistant persister cells, and genotypically
resistant cells selected by antibiotic exposure in biofilms
[15,16].
Antibiotic treatment based on standard in vitro suscep-
tibility tests designed for planktonic bacteria, such as the
Clinical and Laboratory Standards Institute (CLSI)
method, fails to clear biofilm-related CoNS infections. It
would therefore seem more appropriate to base the treat-
ment on susceptibility profiles of CoNS grown as bio-
films. Numerous studies have been conducted to
compare the antibiotic susceptibilities of biofilm-grown
bacteria and their planktonic counterparts, but different
results were reported [17,19,20]. Most studies found that
biofilm-grown bacteria were 100-1000 times more resis-
tant than their planktonic counterparts [18-20], however,
Spoering and Lewis (2001) stated that bacteria grown as
biofilms and planktonic cells had similar antibiotic sus-
ceptibilities [17]. This inconsistency could be explained
by the differences in methodologies used. Some studies
[19-21] compared susceptibilities of planktonic cultures
at ~5 × 105 CFU/ml with mature biofilms, which contain
~1010-11 CFU/ml of individual bacteria. It has been shown
that antibiotic resistance of Staphylococcus spp. is inocu-
lum size dependent [22]. Others [21,23,24] compared
standard MICs that target growth inhibition, with mini-
mum biofilm eradication concentrations (MBECs) that
target complete bacterial killing.
Distinct bacterial activities are found in different
phases of biofilm-related infections. In the febrile phase,
large numbers of planktonic cells originating from the
biofilms are present in the surrounding tissues or the
bloodstream, and are responsible for the acute inflamma-
tory response. This transitory phase is followed by a pro-
longed chronic phase, in which biofilm bacteria are more
likely to remain static and cause milder clinical symptoms
[12,25]. When immune competence is weakened or anti-
microbial stresses subside, biofilms can be re-activated
and cells can again detach and colonize other sites to
cause new symptoms locally or remotely [26,27].
The biofilm MIC is an in vitro guide to antibiotic use to
prevent biofilms from releasing planktonic cells and
establishing the febrile phase of infections [23,24]. Ceri et
al. (2001) suggested that conventional CLSI MICs could
be used to represent biofilm MICs to inform antibiotic
treatment, as these two values were generally similar [23].
However, other studies [24,28] have found that biofilm
MICs of some antibiotics are significantly higher than the
CLSI MICs. In the chronic phase of biofilm infections
which are characterised by less active dispersal, the
MBEC, which targets complete bacterial killing would be
more meaningful than the biofilm MIC in predicting the
clinical response [20,23]. The MBEC is an impractical
goal when conventional antibiotics are used in vitro
[3,29], but the biofilm MBC, which targets 99.9% killing
of biofilm-grown bacteria, may be achievable.
Biofilms produced by CoNS consist principally of a
polysaccharide intercellular adhesin (PIA), which is
encoded by the icaADBC operon [8]. Tetracycline, eryth-
romycinand quinupristin-dalfopristin,at subinhibitory
concentrations, were reported to enhance CoNS biofilm
formation by stimulating ica expression, whereas no positive
effect was found for penicillin,oxacillin, chloramphenicol,
clindamycin, gentamicin, ofloxacin, vancomycin, or tei-
coplanin [30-32]. Most previous studies examined the
effect of antibiotics on biofilm formation of planktonic
bacteria [30-32], whereas established mature biofilms are
more commonly encountered in infections of VLBW
infants in NICUs. In addition, those studies examined the
effect of antibiotics at subinhibitory concentrations; how-
ever concentrations achievable in serum would be more
clinically relevant.
The objectives of this study were to (i) compare the
antibiotic susceptibility of CoNS in different stages of
biofilm formation (ii) assess the contribution of polysac-
charide to resistance of biofilm-grown bacteria to antibi-
otics (iii) determine any stimulatory effects of the first
line antibiotics used in NICUs on preformed CoNS bio-
films.
Methods
Staphylococcal isolates
Twenty-four CoNS isolates from blood cultures of VLBW
newborns receiving treatment at the Royal Women's
Hospital (RWH) NICU were examined to obtain an over-
all view of the antibiotic susceptibility patterns of strains
circulating in the unit and to determine the effect of anti-
biotics at serum achievable concentrations on preformed
biofilms (Table 1) [33]. These isolates were identified pre-
viously to species level, examined for their ability to pro-
duce biofilms and classified as invasive isolates or
probable contaminants [33] according to the definition of
sepsis in CDC-NNIS (United States Centre for Disease
Control and Prevention National Nosocomial Infection
Surveillance System). Our previous studies suggested that
these circulating strains were from a common pool [33].
For detailed studies of the antibiotic susceptibility pat-
terns of CoNS in different growth modes, nine represen-
tative isolates were selected. These isolates included twoQu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
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biofilm-positive  S. epidermidis (isolates 3 and 11), one
biofilm-negative S. epidermidis (isolate 19), two biofilm-
positive Staphylococcus capitis (isolates 8a and 9), two
biofilm-weak/negative S. capitis (isolates 15 and 22), and
two reference strains, S. epidermidis ATCC 35984
(RP62A) and Staphylococcus hominis ATCC 35982 (SP2),
which were used as controls of biofilm-positive and bio-
film-negative strains respectively.
Antibiotics
The antibiotics chosen for this study included those com-
monly used in NICUs for the management of neonatal
sepsis; penicillin G (benzyl penicillin), gentamicin, vanco-
mycin, and oxacillin. In the RWH NICU, the first line
empiric treatment for early onset sepsis (first 48 h of life)
is penicillin and gentamicin, and for late onset sepsis (>48
h), the choice is either flucloxacillin or vancomycin with
gentamicin. Ciprofloxacin and rifampicin were also eval-
uated in this study as the efficacy of these antibiotics on
CoNS biofilms has been reported by other in vitro stud-
ies. Penicillin G was purchased from CSL Biotherapies,
Parkville, Australia and all others were obtained from
Sigma-Aldrich, Castle Hill, Australia.
Establishment of adherent monolayers
B a c t e r i a l  c u l t u r e s  o f  a d h e r e n t  m o n o l a y e r s  w e r e  e s t a b -
lished following the method of Miyake et al. (1992),
which involved the addition of 50 μL volumes of bacterial
Table 1: Bacterial isolates and growth media used for biofilm formation.
Isolate Species Status Growth medium for biofilm formationa
TSB TSB+1% glucose TSB+4% NaCl icaA icaC icaD
1 S. warneri Invasive + - - -
2 S. haemolyticus Invasive - - - -
3 S. epidermidis Invasive + + + +
4 S. epidermidis Invasive + - - -
5 S. epidermidis Invasive + + + +
6 S. capitis Invasive + + + -
7 S. epidermidis Invasive + + + +
8a S. capitis Invasive + + + -
8b S. capitis Invasive + + + -
9 S. capitis Invasive + + + -
10 S. epidermidis Invasive + - - -
11 S. epidermidis Invasive + + + +
12 S. epidermidis Contaminant w - - -
13 S. epidermidis Contaminant + + + +
15 S. capitis Contaminant w + + -
16 S. capitis Contaminant + + + -
17 S. capitis Contaminant + + + -
18 S. capitis Contaminant + + + -
19 S. epidermidis Contaminant - - - -
20 S. epidermidis Contaminant + + + +
21 S. epidermidis Contaminant + + + +
22 S. capitis Contaminant w + + +
23 S. epidermidis Contaminant + + + +
24 S. epidermidis Contaminant + + + +
RP62A S. epidermidis Reference +
SP2 S. hominis Reference -
a Selection of growth medium was based on the production of the highest biofilm density for each isolate. The amount of biofilm was 
indicated as: "+", strong (OD600 ≥ 0.24); "w", weak (0.12≤ OD600 <0.24); "-", negative (OD600 <0.12). Isolates 8a and 8b were from the same baby, 
collected at different episodes of sepsis. Isolate 14 was not available for this study.Qu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
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suspension (1 × 106 CFU/ml in TSB) into wells of a 96-
well flat-bottom microplate (Nunclon Delta; NUNC,
Roskile, Denmark) [34]. The microplates were then cen-
trifuged at 20°C for 10 min at 450 × g, followed by incuba-
tion at 35°C for 1 h. Non-adherent bacterial cells were
removed by gently washing each well twice with 100 μL
phosphate buffered saline (PBS, Amresco, Solon, Ohio,
USA). The number of cells in adherent monolayers was
determined by a series of steps: adding 100 μL PBS into
each well, scraping the wells with sterile pipette tips,
swabbing the wells with a cotton-tipped swab, mixing the
contents, and pipetting 10 μL of the content for viable
counts. The average bacterial count of four wells (column
12, row A-D) was used to represent all the monolayers in
the microplates before any treatment.
Establishment of mature biofilms
Biofilm bacterial culture was set up by a modification of
an established method [35]. Briefly, a bacterial suspen-
sion of McFarland 0.5 (~ 108 CFU/ml) was diluted 1:100
into different diluents: TSB, TSB with 1% glucose or TSB
with 4% NaCl, aiming to produce maximum amounts of
biofilms for each individual isolate (Table 1) [33]. One
hundred microlitres of the diluted bacterial suspensions
were pipetted into each well in a 96-well flat-bottom
microplate and incubated for 18-24 h at 35°C without
shaking. After overnight incubation, the bacterial suspen-
sions were aspirated and the wells were rinsed twice with
100 μL of PBS per well to remove non-adherent bacteria.
After establishing biofilms in the 96-well microplate, the
colony counts in four wells (column 12, rows A-D) were
determined by the method of Cualtieri et al. (2006, 2007)
and the mean was used to represent all biofilms in the
microplates [36,37]. One hundred millilitres of Mueller-
Hinton broth (MHB, Oxoid, Hampshire, England) was
added into microwells containing biofilms. The biofilm
matrix was then scraped with a sterile pipette tip, soni-
cated (Branson 450 digital sonifier with a microtip) for 8 s
(4 × 2 s) at 10% of the maximum amplitude and viable
counts were then performed.
MICs for planktonic cells at mid-log phase and adherent 
monolayers
The MICs of single antibiotics for planktonic cells at mid-
log phase were determined by standard broth microdilu-
tion [38]. To examine the MICs of single antibiotics for
adherent monolayers, one hundred microliter volumes of
twofold serial dilutions of antibiotics, ranging from 128
μg/ml to 0.001 μg/ml, in MHB or MHB plus 1% NaCl (for
oxacillin) were added to microwells with established
adherent monolayers. Plates were incubated at 35°C aero-
bically for 18 h (for all antibiotics except oxacillin and
vancomycin) or 24 h (for oxacillin and vancomycin).
MICs for both planktonic cells and adherent monolayers
were defined as the lowest concentration of antibiotics
that prevented the establishment of visible turbidity after
overnight exposure.
MBCs for planktonic cells at mid-log phase and adherent 
monolayers
The minimum bactericidal concentrations (MBCs) of the
antibiotics against planktonic bacteria at mid-log phase
were determined by a standard method (10). The log
reduction for adherent monolayers was calculated by
dividing the pre-determined viable count in the untreated
wells by the viable counts in individual wells after antibi-
otic exposure. The monolayer MBC was defined as the
lowest concentrations of antibiotics that reduced bacte-
rial numbers by 3 logs.
MICs for biofilm-grown bacteria
MICs using bacteria at stationary phase could not be
tested by standard procedures as the maximum cell den-
sity had already been reached. The method to determine
MICs for biofilm-grown bacteria was adapted from that
of Ceri et al. (2001) [23]. Biofilms were established in 96-
well microplates and exposed to 100 μL of twofold serial
dilutions of antibiotics ranging from 1024 μg/ml to 0.001
μg/ml, in MHB or MHB plus 1% NaCl (for oxacillin).
Microplates were then incubated at 35°C for 18 or 24 h,
depending on the antibiotics tested. After overnight chal-
lenge, the supernatants from each well were carefully
transferred to wells in a new 96-well microplate without
disturbing the biofilms, and the turbidity of the contents
was visually assessed. The biofilm MIC was defined as the
lowest concentration of antibiotic at which no visible
growth was observed. When exposed to antibiotics at or
above this concentration, the planktonic bacterial popu-
lation could not be established by bacterial shedding from
the biofilms.
MBCs for biofilms and planktonic cells at stationary phase
Determination of MBCs for the biofilms was also based
on the reduction in viable counts after overnight expo-
sure to antibiotics. After the MICs of the antibiotics for
biofilms had been determined, the viable bacteria
remaining in biofilms in wells with antibiotic concentra-
tions above MICs were counted. MBCs for biofilms were
calculated by dividing the pre-determined viable count of
untreated biofilms by the viable counts of specified wells
after antibiotic exposure. The MBCs of the antibiotics
against planktonic bacteria at stationary phase were
determined following the CLSI guidelines (2004) except
that stationary phase cultures replaced log-phase cultures
[38]. The MBCs for planktonic cells at stationary phase
and for biofilms were defined as the minimum concentra-
tion of antibiotics required to reduce bacterial numbers
by at least 3 logs.Qu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
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Effects of antibiotics at the highest achievable serum 
concentration on preformed biofilms
To determine the effects of conventional antibiotics on
established biofilms, 100 μL volumes of TSB alone or of
TSB containing the antibiotics at the highest serum
achievable concentration (32 μg/ml for oxacillin, 32 μg/
ml for vancomycin, 8 μg/ml for gentamicin) were added
to established biofilms [39]. After incubation at 35°C for
24 h, the medium was aspirated from the wells and the
biofilms were washed three times with PBS and then
stained by 50 μl Hucker crystal violet (Merck, Kilsyth,
Australia). Quantification of the biofilms was carried out
by reading the absorbance OD600 as previously described
[35]. Differences between the OD600 values of test wells
and antibiotic-free wells were considered as an enhance-
ment or reduction of the biofilms, depending on the
trend of the change. After determination of antibiotic-
bacteria combinations which showed increases in OD600
in spite of antibiotic challenge, epifluorescence micros-
copy and confocal laser scanning microscopy (CLSM)
were performed to confirm the enhancement effect of
antibiotics. In addition, a dose-response study was car-
ried out for these combinations.
Phase contrast microscopy, epifluorescence microscopy 
and confocal laser scanning microscopy
Phase contrast microscopy (Olympus 1 × 51, Hachioji,
Japan) was used to examine the morphology of adherent
monolayers formed by all 24 CoNS clinical isolates and
two control isolates. Epifluorescence microscopy and
confocal laser scanning microscopy was carried out to
assess whether the increased amount of biofilm induced
b y  a n t i b i o t i c  e x p o s u r e  w a s  d u e  t o  a n  i n c r e a s e  i n  t h e
amount of polysaccharide or bacterial cells, and to exam-
ine the viability of the biofilm cells after antibiotic chal-
lenge. After overnight exposure to the specific antibiotic,
microwells containing CoNS biofilms were rinsed with
200 μl of 0.9% NaCl three times. Bacterial attachment and
viability was then assayed with the LIVE/DEAD BacLight
bacterial viability kit (Molecular Probes Inc., Eugene,
OR), by adding 200 μl of a mixed solution of SYTO 9 (5
μM) (staining living cells) and propidium iodide (PI, 30
μM) (staining dead cells) into each well, and incubating
the microplate at room temperature in the dark for 15
min. In parallel, 200 μl of a fluorescent dye specific for
CoNS polysaccharide, Alexa Fluor 555 conjugated wheat
germ agglutinin (10 μg/ml) (Molecular Probes Inc.,
Eugene, OR), were added to untreated and antibiotic
treated biofilms, which were stained for 1 h in the dark.
The biofilms were then examined by a Nikon Diaphot
inverted fluorescence microscope equipped with B2 filter
sets and G-2A filter sets, and by a Nikon Eclipse Ti
inverted microscope equipped with Nikon A1R Fast
Laser Scanning Confocal system. In CLSM experiments,
samples were scanned frame-by-frame, at 488 nm to
observe the live cells and at 561 nm for detection of dead
cells and polysaccharide. A representative area in the cen-
tre of microwells was chosen for both epifluorescence
microscopy and CLSM imaging.
Data analysis
CLSI MIC experiments were repeated three times in trip-
licate. All other MIC and MBC experiments were
repeated on three different occasions, and a fourth test
was performed if the values were not identical. The geo-
metric mean (log2) was calculated and used for compari-
son. Based on the acceptable range of MIC for antibiotic
quality control for Staphylococcus aureus ATCC 25913,
an increase of > 2 × log2 in MIC or MBC for oxacillin,
vancomycin, ciprofloxacin and rifampicin, and an
increase of > 3 × log2 for MIC or MBC for penicillin and
gentamicin, were considered significant [38]. Experi-
ments targeting the effects of antibiotics on preformed
biofilms were repeated at least three times in triplicate.
One way analysis of variance (ANOVA) or the non-para-
metric Mann-Whitney test was used for two-set compar-
isons and a p-value of < 0.05 was considered significant.
Results
Structure of adherent monolayers
The establishment of adherent monolayers of all 26 CoNS
isolates after 1 h incubation in 96-well microplates was
confirmed with 40 × 10 phase-contrast microscopy. A
microcolony structure characteristic of biofilms was
observed when incubation time was extended to 2 h for
biofilm-positive CoNS.
Susceptibilities of CoNS to conventional antibiotics
Most CoNS were resistant to penicillin G (100%), gen-
tamicin (83%), and oxacillin (92%), and remained suscep-
tible to vancomycin (100%), ciprofloxacin (100%) and
rifampicin (79%). There was no significant difference in
resistance profiles of invasive and contaminating strains
(p ≥ 0.05) (data not shown).
Comparison of antibiotic susceptibilities of CoNS grown in 
different modes
Adherent monolayers compared with planktonic cultures at 
mid-log phase
In general, there were no significant differences in antibi-
otic susceptibility between planktonic cells at mid-log
phase and adherent monolayers (determined by MIC and
MBC). Two exceptions were: 1) MBCs of penicillin were
16 times higher for monolayer-grown S. epidermidis
RP62A and S. hominis SP2 than planktonic cells, 2) MICs
and MBCs of oxacillin were 8 times higher for mono-
layer-grown cells of isolate 8a than for planktonic cells
(see underlined values in (Tables 2 and 3).Qu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
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Biofilms compared with planktonic cultures at mid-log phase 
and adherent monolayers
Differences between susceptibilities of biofilm-grown
cells and planktonic cells at mid-log phase were antibiotic
dependent (Tables 2 and 3). The MICs of gentamicin, cip-
rofloxacin, and rifampicin were similar for most CoNS
isolates studied. However, the MICs of three cell wall
active antibiotics were significantly higher for biofilm
cells than for planktonic cells at mid log-phase (32-256
times for penicillin G for 7 of 9 CoNS isolates, 8-32 times
for oxacillin for 6 of 9 isolates, and 8 times for vancomy-
cin for 5 of 9 isolates) (see bolded values in Tables 2 and
3). The MBCs of all antibiotics except rifampicin were
significantly higher for isolates grown as biofilm cells
than planktonic cells at mid-log phase. Five of nine iso-
lates were equally susceptible to killing by rifampicin as
biofilms and planktonic cells in mid-log phase. Adherent
monolayers showed similar trends to planktonic cultures
at mid-log phase (see bolded values in Tables 2 and 3).
Biofilms compared with planktonic cultures at stationary 
phase
The MBCs of most antibiotics were above the upper limit
of detection (≥ 1024 μg/ml) for most CoNS isolates when
grown as either planktonic cells at stationary phase or
biofilms. For antibiotic/isolate combinations for which
the MBCs could be compared between these two growth
modes (n = 22), planktonic cells at stationary phase were
either equally resistant (n = 7) or more resistant (n = 13)
than biofilm cells (see italicised values in Table 2 and 3).
There was little difference between biofilm-positive
and biofilm-negative phenotypes in their relative resis-
tance to most antibiotics whether grown as planktonic
cells, adherent monolayers or biofilms. However, most
biofilm-positive, but few biofilm-negative isolates were
more resistant to vancomycin (increased MICs) and
rifampicin (increased MBC) in the biofilm mode than
planktonic cells or adherent monolayers (Tables 2 and 3).
Effects of antibiotics at the highest achievable serum 
concentration on preformed CoNS biofilms
The effects of oxacillin, gentamicin, vancomycin and
their combination at the highest achievable serum con-
centrations on preformed biofilms of 24 CoNS clinical
isolates are presented in Table 4. Vancomycin or combi-
nations of vancomycin with oxacillin and gentamicin
were the most effective in reducing the density of pre-
formed biofilms (58.3%); followed by oxacillin (29.2%)
and gentamicin (8.3%). Oxacillin stimulated biofilm
growth of two S. capitis isolates (isolates 15 and 22), con-
verting these biofilm-negative isolates (OD600  < 0.12,
when grown with TSB) into weak biofilm producers (0.12
≤ OD600  < 0.24) or even biofilm-positive phenotypes
(OD600 ≥ 0.24) (Figure 1 and Figure 2). S. epidermidis iso-
late 19 also showed enhancement of biofilm in the pres-
ence of oxacillin but the difference did not quite reach
clinical significance (p  < 0.074). Similar findings were
obtained when 1% glucose was added into TSB as the
medium for biofilm growth (data not shown). Dose-
response studies using isolates 15 and 22 confirmed that
oxacillin at concentrations ranging from 0.25 to128 μg/ml
enhanced the biofilm-mode growth, with peak enhance-
ment occurring around 8 to 32 μg/ml (data not shown).
Microscopic analysis of the CoNS biofilm enhancement by 
oxacillin
In crystal violet staining, epifluorescence microscopy,
and CLSM imaging experiments, exposure to oxacillin at
32 μg/mL increased the thickness of biofilms of both iso-
lates 15 and 22. Figure 2 show a representative field of
view obtained for isolate 15. In CLSM imaging experi-
ment, the Live/Dead BacLight bacterial viability kit and
Alexa Fluor 555 conjugated wheat germ agglutinin were
applied to the biofilm formed by isolates 15 and 22 before
and after exposure to oxacillin at 32 μg/ml. For both iso-
lates, oxacillin stimulated the production of polysaccha-
ride (Figures 2a and 2c), and the multiplication of living
cells attached to the polystyrene surface (Figures 2b and
2d).
Dicussion
The prevalence of antibiotic resistance of CoNS isolated
from VLBW infants in the NICU at RWH, was similar to
that of a previous study (100%, 93%, 80%, 4% and 0%
resistant to ampicillin, methicillin, gentamicin, ciproflox-
acin and vancomycin respectively) [40]. Invasive isolates
and contaminants exhibited similar susceptibilities. The
same groups of invasive and contaminating isolates
showed no differences in biofilm production or posses-
sion of the ica genes [33], suggesting that resistant strains
were acquired initially as skin flora and subsequently
caused invasive infections in susceptible infants.
This is the most comprehensive study so far to compare
antibiotic susceptibilities of bacteria in the whole range of
growth modes relevant to biofilm resistance. Planktonic
cultures at mid-log phase, adherent monolayers, mature
biofilms and planktonic cultures at stationary phase were
assessed for their susceptibilities to multiple antibiotics.
The rationale was to challenge bacterial cultures at differ-
ent stages and modes of growth with the same amount of
antibiotic. In particular, we wanted to compare the sus-
ceptibilities of biofilm-grown cells and planktonic cells of
the same cell density.
The nine representative strains used in our study gener-
ally showed similar changes in antibiotic resistance in
response to changes of growth modes, regardless of their
different species and sources. In agreement with the
study by Labthavikul et al.(2003), we found that MICs and
MBCs were generally similar when CoNS were grown inQu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
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the planktonic mode or as adherent monolayers [41]. The
few exceptions were three isolates that were more resis-
tant in the adherent monolayer form to β-lactam antibi-
otics; penicillin and oxacillin. Other studies found that S.
aureus,  Escherichia coli and Pseudomonas aeruginosa
were significantly more resistant to both growth inhibi-
tion and killing in the adherent form than in the plank-
tonic form [19,34]. This difference could possibly be
explained by different responses to antibiotics by individ-
ual species [19]. Different methods used for monolayer
formation might also be responsible for the different
findings from these studies. Miyake and colleagues (1992)
challenged  S. aureus monolayers after 1 h incubation
while Aaron et al. challenged 2 h monolayers of P. aerugi-
nosa[19,34]. In our preliminary study, we found that most
biofilm-positive CoNS formed microcolonies after incu-
bation for 2 h. Microcolonies represent early stage of bio-
film formation and demonstrate some properties of
biofilms [42]. Thus it is possible that the study of Aaron et
al. (2002) examined early-stage biofilms rather than
Table 2: Antibiotic susceptibilities of five biofilm-positive isolatesa grown in different modes.
Isolate and 
mode of 
growth
Initial bacterial 
density (CFU/ml)
Penicillin
(μg/ml)
Gentamicin
(μg/ml)
Oxacillin
(μg/ml)
Vancomycin
(μg/ml)
Ciprofloxacin
(μg/ml)
Rifampicin
(μg/ml)
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
RP62A
Log Planktonic (2.6-7.3)× 105 8 8 16 32 64 64 2 2 0.06 0.12 0.008 0.03
Monolayer (6.0-15.6) × 105 32 128c 64 64 16 64 2 8 0.12 0.12 0.002 0.008
Stat Planktonic (0.2-0.5) × 109b > 1024 1024 > 1024 32 ≤1 32
Biofilm (0.9-1.9) × 109 >1024e >1024 64 >1024 64 >1024 16 >1024d 0.25 >1024 0.004 0.015
Isolate 3
Log Planktonic (2.9-8.3) × 105 8 16 0.25 0.25 0.25 0.25 2 4 0.12 0.25 0.008 0.015
Monolayer (5.0-11.0) × 105 32 64 0.25 0.5 0.12 0.5 2 8 0.25 0.5 0.002 0.004
Stat Planktonic (0.6-2.2) × 109 >1024 32 >1024 >1024 1024 256
Biofilm (0.3-1.3) × 109 >1024 >1024 16 16 0.25 21 6 16 0.25 20 . 5 4
Isolate 8a
Log Planktonic (2.6-5.5) × 105 128 128 32 32 8 8 1 2 0.25 0.25 0.008 0.03
Monolayer (6.4-11.1) × 105 >128 >128 32 64 64 64 1 8 0.12 0.5 0.004 0.015
Stat Planktonic (4.4-4.9) × 108 >1024 >1024 >1024 >1024 1024 2
Biofilm (0.6-1.8) × 108 1024 >1024 256 >1024 256 >1024 8 >1024 0.12 >1024 0.004 4
Isolate 9
Log Planktonic (3.1-5.2) × 105 32 64 32 32 8 16 1 2 0.25 0.25 0.015 0.03
Monolayer (4.6-10.8) × 105 >128 >128 32 >128 16 32 2 8 0.25 0.5 0.004 0.015
Stat Planktonic (0.7-0.8) × 109 >1024 >1024 >1024 >1024 >1024 256
Biofilm (1.1-1.7) × 109 >1024 >1024 64 >1024 >128 >1024 8 >1024 0.25 >1024 0.008 4
Isolate 11
Log Planktonic (2.7-8.5) × 105 8 8 64 >128 32 64 1 1 0.06 0.12 >128 >128
Monolayer (3.2-17.8) × 105 32 64 >128 >128 32 64 1 2 0.06 0.12 >128 >128
Stat Planktonic (0.8-1.6) × 109 >1024 >1024 >1024 >1024 512 1024
Biofilm (0.2-0.6) × 109 >1024 >1024 256 >1024 256 >1024 8 >1024 0.25 16 64 >1024
α Biofilm-positive isolates (OD600 >0.24).
b MICs for CoNS at stationary phase are not provided as the values could not be determined by standard methods.
c Values underlined indicate a significant increase in the MICs or MBCs between log-planktonic and adherent monolayer modes of growth.
d Values in italic indicate a significant change in the MBCs between stationary-planktonic and biofilm modes of growth.
e Values in bold indicate a significant increase in MICs or MBCs between log-planktonic/adherent monolayer and biofilm modes of growthQu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
http://www.ann-clinmicrob.com/content/9/1/16
Page 8 of 12
adherent monolayers, however , it is also likely that the
difference was due to the different kinetics of biofilm for-
mation between P. aeruginosa and Staphylococcus spp.
[19].
Conventional MICs have been used to guide the treat-
ment of biofilm-related infections at the febrile stage,
based on the assumption that biofilm-released cells are
similar in their susceptibilities to cells in the planktonic
phase [23]. Reported differences between the conven-
tional MICs and biofilm MICs were attributed to lack of
standardization of initial inocula and to the presence of
small colony variants [23]. However, in our study, we
found that MICs of cell wall active antibiotics were fre-
quently higher for biofilm grown bacteria than planktonic
cultures. This is consistent with recent studies by
Moskowitz et al. (2004) and Melchior et al. (2006), who
reported that biofilm MICs of β-lactam antibiotics, but
not other antibiotics, were much higher than the conven-
tional MICs for P. aeruginosa and S. aureus respectively
[21,24]. These results are not surprising given that cell
wall active antibiotics mainly affect rapidly growing bac-
teria. Biofilm-released cells are likely to be less active than
dividing planktonic cells at mid-log phase, probably
because they have recently undergone a switch from a
biofilm mode of growth to a free-living mode, similar to
cells at lag-phase growth, and require a change in gene
expression to adapt to the new environment.
The MBCs of penicillin G, gentamicin, oxacillin, and
vancomycin for CoNS grown in a biofilm mode were gen-
erally > 1024 μg/ml, which is well beyond the highest
achievable serum concentrations. Although some of
these antibiotics at the highest achievable serum concen-
trations were effective against bacteria grown planktoni-
cally to mid-log phase, they were inadequate to kill
Table 3: Antibiotic susceptibility of four biofilm-negative isolatesa grown in different modes.
Isolate and 
mode of growth
Initial bacterial 
density (CFU/ml)
Penicillin
(μg/ml)
Gentamicin
(μg/ml)
Oxacillin
(μg/ml)
Vancomycin
(μg/ml)
Ciprofloxacin
(μg/ml)
Rifampicin
(μg/ml)
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC
SP2
Log Planktonic (1.2-4.1) × 105 0. 5 0. 5 8 8 0.06 0.06 1 2 0.12 0.12 0.008 0.03
Monolayer (2.6-4.7) × 105 2 8c 16 16 0.12 0.12 0.5 1 0.12 0.12 0.004 0.008
Stat Planktonic (3.5-9.5) × 107b >1024 1024d 2 4 2 0.008
Biofilm (1.0-3.2) × 107 128 >1024e 83 20 . 1 2 2 2 4 0.12 2 0.002 0.008
Isolate 15
Log Planktonic (2.2-5.5) × 105 128 128 32 64 16 32 4 4 0.25 0.25 0.015 0.03
Monolayer (5.2-16.4) × 105 >128 >128 32 64 16 64 4 8 0.12 0.25 0.004 0.008
Stat Planktonic (3.7-7.9) × 108 >1024 >1024 >1024 >1024 >1024 64
Biofilm (0.7-0.9) × 108 >1024 >1024 256 >1024 256 >1024 16 >1024 0.25 512 0.004 0.008
Isolate 19
Log Planktonic (2.9-7.4) × 105 >128 >128 64 64 2 8 2 2 0.25 0.25 0.008 0.015
Monolayer (3.2-14.6) × 105 >128 >128 64 >128 2 8 2 8 0.12 0.25 0.002 0.008
Stat Planktonic (0.7-1.5) × 109 >1024 >1024 >1024 >1024 1024 2
Biofilm (0.1-0.2) × 109 1024 >1024 64 >1024 64 >1024 4> 1024 0.25 4 0.008 0.06
Isolate 22
Log Planktonic (2.8-5.6) × 105 >128 >128 64 64 8 16 4 4 0.12 0.25 0.015 0.03
Monolayer (4.8-16.3) × 105 >128 >128 32 >128 32 32 2 8 0.12 0.25 0.004 0.008
Stat Planktonic (0.5-0.7) × 109 >1024 >1024 >1024 >1024 >1024 256
Biofilm 0.2 × 109 1024 >1024 >128 >1024 >128 >1024 16 >1024 0.25 1 0.008 0.03
a Biofilm-negative isolates included biofilm-weak producer (0.24 >OD600≥ 0.12) and biofilm-negative producer (OD600 <0.12).
b MICs for CoNS at stationary phase are not provided as the values could not be determined by standard methods.
c Values underlined indicate a significant increase in the MICs or MBCs between log-planktonic and adherent monolayer modes of growth.
d Values in italics indicate a significant change in the MBCs between stationary planktonic and biofilm modes of growth.
e Values in bold indicate a significant increase in MICs or MBCs between log-planktonic/adherent monolayer and biofilm modes of growth.Qu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
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Page 9 of 12
bacterial biofilms. Administration of a single antibiotic to
newborns with catheter-associated infections, based on
the results of in vitro susceptibility tests designed for
planktonic bacteria at mid-log phase, is unlikely to reach
an effective concentration to eradicate the bacteria
adherent to the catheters. This may be one of the reasons
that explain the frequent failure of treating CoNS infec-
tions with conventional antibiotics in patients with for-
eign body infections when the devices are not removed.
The MBCs of rifampicin and ciprofloxacin were gener-
ally higher for planktonic cells in stationary phase than
their biofilm-grown counterparts. This is consistent with
the finding of Spoering and Lewis (2001), that stationary
phase cultures showed similar or higher resistance than
biofilm-grown bacteria [17].
A possible limitation of this study was the assessment
of killing of biofilm bacteria using the biofilm MBC,
which leaves 0.1% of the challenged cells out of our con-
sideration. This remaining 0.1% population might contain
"persister cells", which have been considered as an impor-
tant mechanism of biofilm resistance [17]. While the end-
point of complete killing may be more desirable, MBECs
of the first-line antibiotics used in NICUs were far above
the upper detection limit used in this study (1024 μg/ml)
[29].
An important aim of this study was to investigate the
effect of antibiotics on the various stages of biofilm devel-
opment. On initial attachment to a polymer surface,
CoNS may be susceptible to antibiotics, but resistance
increases as the biofilm develops. These findings high-
light the importance of early recognition and treatment
of catheter-related neonatal sepsis. At the early attach-
ment stage success is possible with the widely used first-
line antibiotics guided by conventional susceptibility
tests. It should be noted that some CoNS are more resis-
tant to β-lactam antibiotics in the adherent monola yer
phase. Once biofilms have developed, cell-wall active
antibiotics often fail to resolve the febrile phase of the
infection, as these antibiotics at CLSI MIC cannot reliably
prevent biofilms from releasing free-living cells. More-
over, most antibiotics, with the exception of rifampicin,
are incapable of killing CoNS within the biofilm.
No significant difference was found in the response to
antibiotics between biofilm-negative and biofilm-positive
phenotypes. However, it is important to note that isolates
classified as biofilm-negative (OD600 < 0.12), if grown
under biofilm assay conditions, do produce densely-
grown microcolonies [43]. This information, together
with our finding that there was little difference in suscep-
tibility between biofilm-grown bacteria and planktonic-
grown bacteria of the same density, suggests that a
densely adherent growth mode is an important determi-
nants of biofilm resistance. Although this finding is con-
trary to the current belief that higher biofilm-forming
ability is associated with antibiotic resistance [42,44], it is
supported by studies that reported no correlation
Figure 1 Enhancement of biofilm-mode growth of CoNS cells by oxacillin at the highest serum achievable concentration. Solutions of gen-
tamicin, oxacillin, vancomycin or the three agents in combination in TSB at the highest concentrations achievable in serum, were added to biofilm 
grown cells of two S. capitis isolates; 15 (biofilm-negative, ica-weak), and 22 (biofilm-negative, ica-positive).  After overnight incubation, bacterial 
growth was stained with crystal violet and the OD600 was measured.  Error bars represent standard errors of at least 3 individual experiments in tripli-
cate.  *: P = 0.004; ** P < 0.001.  
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between the amount of slime produced and antibiotic
susceptibility of S. epidermidis[41,45]. Moreover, we have
reported a similar level of resistance of CoNS isolates to
antibiotic lock solutions, regardless of the amount of bio-
film produced [29].
To our knowledge, this is the first study to investigate
whether commonly used antibiotics at the highest achiev-
able serum concentrations are able to stimulate the
growth of established biofilms. It is also the first study
which visually demonstrates the enhancing effect of
external stimuli on two principal components of biofilms;
polysaccharide and biofilm bacteria. Other studies
focused on the effect of antibiotics at subinhibitory con-
centrations on development of biofilms [31,46]. Rachid et
al. (2000) showed that oxacillin at subinhibitory concen-
tration did not induce the expression of ica operon and
biofilm formation [31]. Different subspecies/strains and
concentration of oxacillin used by these investigators
might explain the lack of biofilm enhancement by oxacil-
lin. Cerca et al. (2005) reported that exposure to subin-
Figure 2 Enhancement of the biofilm growth of isolate 15 by oxacillin at the highest achievable serum concentration*  *: As isolate 15 and 
22 showed similar responses, only the results for isolate 15 are shown.   a and c: stained with Alexa Fluor 555 conjugated wheat germ agglutinin; red 
signal indicates the presence of polysaccharide.  b and d: stained with  Live/Dead BacLight bacterial viability kit; green signal indicates the presence 
of live cells and red signal indicates the presence of dead cells.   
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Table 4: No. of CoNS isolates showing reductiona or enhancement when biofilms/adherent cells exposed to antibiotics.
Effect Number (%) of isolates affected by
Gentamicin (GEN) Oxacillin (OXA) Vancomycin (VAN) GEN, OXA, VAN
Reduction 2 (8) 7 (29) 14 (64) 14 (64)
Enhancement 0 (0) 2 (8) 0 (0) 0 (0)
None 22 (92) 15 (63) 10 (36) 10 (36)
a After overnight antibiotic exposure, the difference in OD600 values between test biofilms and antibiotic-free wells, if greater than intra-
microplate variability, were defined as significant; a decrease was considered a reduction and an increase was considered an enhancement.Qu et al. Annals of Clinical Microbiology and Antimicrobials 2010, 9:16
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hibitory dicloxacillin, an antibiotics structurally similar to
oxacillin, could stimulate the polysaccharide synthesis in
S. haemolytics[30]. In this study, oxacillin at the highest
achievable serum concentration (32 μg/ml) enhanced
biofilm growth of two biofilm-negative S. capitis (both
ica  < positive, oxacillin MIC < 16 μg/ml). Biofilm
enhancement in both S. capitis isolates was related to an
increase of bacterial numbers and in the amount of poly-
saccharide produced. The mechanism of oxacillin
enhancing biofilm formation of S.  capitis  still requires
further investigation. Biofilm production in S. capitis can
be induced by external stresses such as a high NaCl level
through induction of the expression of ica  locus by
repression of tricarboxylic acid cycle [47,48]. It is likely
that the positive influence of oxacillin on biofilm produc-
tion demonstrated in this study is also via the stress-
induced ica expression. The enhancement of biofilm pro-
duction by oxacillin might explain some treatment fail-
ures, as flucloxacillin is frequently used to treat infections
caused by methicillin-sensitive CoNS.
Conclusion
In summary, our study confirmed previous findings that
CoNS in a biofilm mode of growth are highly resistant to
most antibiotics. Most first-line antibiotics used in NICU,
at an achievable serum concentration, failed to eradicate
the CoNS biofilms. Only rifampicin and, in some cases
ciprofloxacin, consistently displayed activity against bio-
film-grown bacteria. Our results also indicated that
either a high-density growth phase or its metabolic state,
which is related to a biofilm growth mode rather than
biofilm-producing ability, contribute significantly to the
resistance of CoNS biofilms to antibiotics. Finally, we
have cited examples of the enhancement of CoNS bio-
films by clinically achievable concentrations oxacillin,
representing the commonly used β-lactam resistant peni-
cillins.
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